280 related articles for article (PubMed ID: 36870394)
1. Novel bispecific human antibody platform specifically targeting a fully open spike conformation potently neutralizes multiple SARS-CoV-2 variants.
Kim JW; Heo K; Kim HJ; Yoo Y; Cho HS; Jang HJ; Lee HY; Ko IY; Woo JR; Cho YB; Lee JH; Yang HR; Shin HG; Choi HL; Hwang K; Kim S; Kim H; Chun K; Lee S
Antiviral Res; 2023 Apr; 212():105576. PubMed ID: 36870394
[TBL] [Abstract][Full Text] [Related]
2. A novel bispecific antibody dual-targeting approach for enhanced neutralization against fast-evolving SARS-CoV-2 variants.
Kim JW; Kim HJ; Heo K; Lee Y; Jang HJ; Lee HY; Park JW; Cho YB; Lee JH; Shin HG; Yang HR; Choi HL; Shim HB; Lee S
Front Immunol; 2023; 14():1271508. PubMed ID: 37822941
[TBL] [Abstract][Full Text] [Related]
3. A Bispecific Antibody Targeting RBD and S2 Potently Neutralizes SARS-CoV-2 Omicron and Other Variants of Concern.
Yuan M; Chen X; Zhu Y; Dong X; Liu Y; Qian Z; Ye L; Liu P
J Virol; 2022 Aug; 96(16):e0077522. PubMed ID: 35916510
[TBL] [Abstract][Full Text] [Related]
4. An Engineered IgG-VHH Bispecific Antibody against SARS-CoV-2 and Its Variants.
Chi H; Wang L; Liu C; Cheng X; Zheng H; Lv L; Tan Y; Zhang N; Zhao S; Wu M; Luo D; Qiu H; Feng R; Fu W; Zhang J; Xiong X; Zhang Y; Zu S; Chen Q; Ye Q; Yan X; Hu Y; Zhang Z; Yan R; Yin J; Lei P; Wang W; Lang G; Shao J; Deng Y; Wang X; Qin C
Small Methods; 2022 Dec; 6(12):e2200932. PubMed ID: 36300882
[TBL] [Abstract][Full Text] [Related]
5. Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concern.
Cho H; Gonzales-Wartz KK; Huang D; Yuan M; Peterson M; Liang J; Beutler N; Torres JL; Cong Y; Postnikova E; Bangaru S; Talana CA; Shi W; Yang ES; Zhang Y; Leung K; Wang L; Peng L; Skinner J; Li S; Wu NC; Liu H; Dacon C; Moyer T; Cohen M; Zhao M; Lee FE; Weinberg RS; Douagi I; Gross R; Schmaljohn C; Pegu A; Mascola JR; Holbrook M; Nemazee D; Rogers TF; Ward AB; Wilson IA; Crompton PD; Tan J
Sci Transl Med; 2021 Oct; 13(616):eabj5413. PubMed ID: 34519517
[TBL] [Abstract][Full Text] [Related]
6. Structural Study of SARS-CoV-2 Antibodies Identifies a Broad-Spectrum Antibody That Neutralizes the Omicron Variant by Disassembling the Spike Trimer.
Zhan W; Tian X; Zhang X; Xing S; Song W; Liu Q; Hao A; Hu Y; Zhang M; Ying T; Chen Z; Lan F; Sun L
J Virol; 2022 Aug; 96(16):e0048022. PubMed ID: 35924918
[TBL] [Abstract][Full Text] [Related]
7. Structural Basis of a Human Neutralizing Antibody Specific to the SARS-CoV-2 Spike Protein Receptor-Binding Domain.
Yang M; Li J; Huang Z; Li H; Wang Y; Wang X; Kang S; Huang X; Wu C; Liu T; Jia Z; Liang J; Yuan X; He S; Chen X; Zhou Z; Chen Q; Liu S; Li J; Zheng H; Liu X; Li K; Yao X; Lang B; Liu L; Liao HX; Chen S
Microbiol Spectr; 2021 Oct; 9(2):e0135221. PubMed ID: 34643438
[TBL] [Abstract][Full Text] [Related]
8. Monospecific and bispecific monoclonal SARS-CoV-2 neutralizing antibodies that maintain potency against B.1.617.
Peng L; Hu Y; Mankowski MC; Ren P; Chen RE; Wei J; Zhao M; Li T; Tripler T; Ye L; Chow RD; Fang Z; Wu C; Dong MB; Cook M; Wang G; Clark P; Nelson B; Klein D; Sutton R; Diamond MS; Wilen CB; Xiong Y; Chen S
Nat Commun; 2022 Mar; 13(1):1638. PubMed ID: 35347138
[TBL] [Abstract][Full Text] [Related]
9. A dual-targeting approach using a human bispecific antibody against the receptor-binding domain of the Middle East Respiratory Syndrome Coronavirus.
Lee JH; Kim JW; Lee HE; Song JY; Cho AH; Hwang JH; Heo K; Lee S
Virus Res; 2024 Jul; 345():199383. PubMed ID: 38697296
[TBL] [Abstract][Full Text] [Related]
10. Bispecific VH/Fab antibodies targeting neutralizing and non-neutralizing Spike epitopes demonstrate enhanced potency against SARS-CoV-2.
Lim SA; Gramespacher JA; Pance K; Rettko NJ; Solomon P; Jin J; Lui I; Elledge SK; Liu J; Bracken CJ; Simmons G; Zhou XX; Leung KK; Wells JA
MAbs; 2021; 13(1):1893426. PubMed ID: 33666135
[TBL] [Abstract][Full Text] [Related]
11. Development and structural basis of a two-MAb cocktail for treating SARS-CoV-2 infections.
Zhang C; Wang Y; Zhu Y; Liu C; Gu C; Xu S; Wang Y; Zhou Y; Wang Y; Han W; Hong X; Yang Y; Zhang X; Wang T; Xu C; Hong Q; Wang S; Zhao Q; Qiao W; Zang J; Kong L; Wang F; Wang H; Qu D; Lavillette D; Tang H; Deng Q; Xie Y; Cong Y; Huang Z
Nat Commun; 2021 Jan; 12(1):264. PubMed ID: 33431876
[TBL] [Abstract][Full Text] [Related]
12. Engineering SARS-CoV-2 specific cocktail antibodies into a bispecific format improves neutralizing potency and breadth.
Ku Z; Xie X; Lin J; Gao P; Wu B; El Sahili A; Su H; Liu Y; Ye X; Tan EY; Li X; Fan X; Goh BC; Xiong W; Boyd H; Muruato AE; Deng H; Xia H; Zou J; Kalveram BK; Menachery VD; Zhang N; Lescar J; Shi PY; An Z
Nat Commun; 2022 Sep; 13(1):5552. PubMed ID: 36138032
[TBL] [Abstract][Full Text] [Related]
13. Antibody cocktail effective against variants of SARS-CoV-2.
Liang KH; Chiang PY; Ko SH; Chou YC; Lu RM; Lin HT; Chen WY; Lin YL; Tao MH; Jan JT; Wu HC
J Biomed Sci; 2021 Nov; 28(1):80. PubMed ID: 34814920
[TBL] [Abstract][Full Text] [Related]
14. A bispecific monomeric nanobody induces spike trimer dimers and neutralizes SARS-CoV-2 in vivo.
Hanke L; Das H; Sheward DJ; Perez Vidakovics L; Urgard E; Moliner-Morro A; Kim C; Karl V; Pankow A; Smith NL; Porebski B; Fernandez-Capetillo O; Sezgin E; Pedersen GK; Coquet JM; Hällberg BM; Murrell B; McInerney GM
Nat Commun; 2022 Jan; 13(1):155. PubMed ID: 35013189
[TBL] [Abstract][Full Text] [Related]
15. A potent human monoclonal antibody with pan-neutralizing activities directly dislocates S trimer of SARS-CoV-2 through binding both up and down forms of RBD.
Wang X; Hu A; Chen X; Zhang Y; Yu F; Yue S; Li A; Zhang J; Pan Z; Yang Y; Lin Y; Gao L; Zhou J; Zhao J; Li F; Shi Y; Huang F; Yang X; Peng Y; Tu L; Zhang H; Zheng H; He J; Zhang H; Xu L; Huang Q; Zhu Y; Deng K; Ye L
Signal Transduct Target Ther; 2022 Apr; 7(1):114. PubMed ID: 35383141
[TBL] [Abstract][Full Text] [Related]
16. Empowering SARS-CoV-2 variant neutralization with a bifunctional antibody engineered with tandem heptad repeat 2 peptides.
Kim JW; Lee JH; Kim HJ; Heo K; Lee Y; Jang HJ; Lee HY; Park JW; Cho YB; Shin HG; Yang HR; Lee HE; Song JY; Lee S
J Med Virol; 2024 Mar; 96(3):e29506. PubMed ID: 38445718
[TBL] [Abstract][Full Text] [Related]
17. B cell genomics behind cross-neutralization of SARS-CoV-2 variants and SARS-CoV.
Scheid JF; Barnes CO; Eraslan B; Hudak A; Keeffe JR; Cosimi LA; Brown EM; Muecksch F; Weisblum Y; Zhang S; Delorey T; Woolley AE; Ghantous F; Park SM; Phillips D; Tusi B; Huey-Tubman KE; Cohen AA; Gnanapragasam PNP; Rzasa K; Hatziioanno T; Durney MA; Gu X; Tada T; Landau NR; West AP; Rozenblatt-Rosen O; Seaman MS; Baden LR; Graham DB; Deguine J; Bieniasz PD; Regev A; Hung D; Bjorkman PJ; Xavier RJ
Cell; 2021 Jun; 184(12):3205-3221.e24. PubMed ID: 34015271
[TBL] [Abstract][Full Text] [Related]
18. Bispecific IgG neutralizes SARS-CoV-2 variants and prevents escape in mice.
De Gasparo R; Pedotti M; Simonelli L; Nickl P; Muecksch F; Cassaniti I; Percivalle E; Lorenzi JCC; Mazzola F; Magrì D; Michalcikova T; Haviernik J; Honig V; Mrazkova B; Polakova N; Fortova A; Tureckova J; Iatsiuk V; Di Girolamo S; Palus M; Zudova D; Bednar P; Bukova I; Bianchini F; Mehn D; Nencka R; Strakova P; Pavlis O; Rozman J; Gioria S; Sammartino JC; Giardina F; Gaiarsa S; Pan-Hammarström Q; Barnes CO; Bjorkman PJ; Calzolai L; Piralla A; Baldanti F; Nussenzweig MC; Bieniasz PD; Hatziioannou T; Prochazka J; Sedlacek R; Robbiani DF; Ruzek D; Varani L
Nature; 2021 May; 593(7859):424-428. PubMed ID: 33767445
[TBL] [Abstract][Full Text] [Related]
19. Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike.
Liu L; Wang P; Nair MS; Yu J; Rapp M; Wang Q; Luo Y; Chan JF; Sahi V; Figueroa A; Guo XV; Cerutti G; Bimela J; Gorman J; Zhou T; Chen Z; Yuen KY; Kwong PD; Sodroski JG; Yin MT; Sheng Z; Huang Y; Shapiro L; Ho DD
Nature; 2020 Aug; 584(7821):450-456. PubMed ID: 32698192
[TBL] [Abstract][Full Text] [Related]
20. Development and Characterization of Phage Display-Derived Monoclonal Antibodies to the S2 Domain of Spike Proteins of Wild-Type SARS-CoV-2 and Multiple Variants.
Kim JW; Cho AH; Shin HG; Jang SH; Cho SY; Lee YR; Lee S
Viruses; 2023 Jan; 15(1):. PubMed ID: 36680213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]